The stock market definitely had a turn-round Tuesday as the indices exploded from the get-go. They ran very sharply higher until midday when they consolidated, and then stair-stepped their way higher at a shallower angle, but still continued strong until the close when they spiked right into the close to finish at the highs for the day going away.

Net on the day, the Dow was up 348.58 at 16,865.08. The S&P 500 was up 46.12 to 1978.35. The Nasdaq 100 was up 132.50 to 4333.61, up 132% and more than 3% for the day.

Advance-declines were 5 to 1 positive on New York Stock Exchange, and 3 1/2 to 1 positive on Nasdaq. Up/down volume was 3 to 1 positive on New York, total volume of 4 3/4 billion shares traded. The Nasdaq traded 2 billion shares and had a 5 to 1 positive volume ratio.

TheTechTrader.com board had a lot of big gainers today. Priceline Inc. (PCLN) was up 30.71 to 1295.92, Google Inc. (GOOG) up 21.04 to 718.81, Apple Inc. (AAPL) up 3.84 to 100.53, Amazon.com Inc. (AMZN) 26.52 to 579.04, and Netflix, Inc. (NFLX) 4.89 to 98.30.

Tesla Motors, Inc. (TSLA), after negative tweets by Citron, was down 5.58 to 186.35 today, but Baidu, Inc. (BIDU) jumped 6.78 to 180.20. Facebook, Inc. (FB) gained 2.90 to 109.82, but First Solar, Inc. (FSLR) gave back 2.85 to 68.02 on a downgrade by JP Morgan.

Biotech’s were particularly strong today. Intrexon Corporation (XON) was up 2.78 to 33.73, Juno Therapeutics Inc. (JUNO) up 4.75 to 39.92, Bristol-Myers Squibb Company (BMY) up 2.29 to 64.22, among many others that did very well today.

Checking the TheTechTrader.com percent-gain leaderboard, ION Geophysical Corporation (IO) led the way, up 95 cents to 4.05, or 31%, on 1.9 million shares, more than 2100% volume than average on positive earnings. Career Education Corp. (CECO) gained 74 cents to 3.26, or 29%, on 2.4 million shares. Apigee Corporation (APIC) bounced 1.00 to 6.85, or 17%, on 1.1 million shares. Amicus Therapeutics, Inc. (FOLD) thrust 69 cents to 6.84, or 11%, on 3.2 million shares. Celldex Therapeutics, Inc. (CLDX) stair-stepped its way higher, up 70 cents to 7.50, or 10%, on 4.7 million shares.

InVivo Therapeutics Holdings Corp. (NVIV) advanced 1.00 to 5.69, or 21%, and American Public Education, Inc. (APEI) jumped 3.38 to 18.81, or 22%.

Among other gainers, Lexicon Pharmaceuticals, Inc. (LXRX) was up 1.51 to 10.85, Kite Pharma, Inc. (KITE) up 6.48 to 51.20, ACADIA Pharmaceuticals Inc. (ACAD) up 1.89 to 19.15, and bluebird bio, Inc. (BLUE) up 4.29 to 50.51, were among the stronger biotech’s today.

The Direxion Daily S&P Biotech Bull 3X ETF (LABU) climbed 79 cents to 6.67.

Stepping back and reviewing the hourly chart patterns, the indices gapped up, ran, consolidated for a bit in a shallow-rising angle, but continued to rise all day into the close.

Let’s see what happens tomorrow.

Good Trading!

In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.

Recommended Content


Recommended Content

Editors’ Picks

EUR/USD trades weak below 1.0800 amid Good Friday lull, ahead of US PCE

EUR/USD trades weak below 1.0800 amid Good Friday lull, ahead of US PCE

EUR/USD continues its downward trend for the fourth consecutive day, driven by a stronger US Dollar influenced by the hawkish market sentiment surrounding the Federal Reserve and expectations of prolonged higher interest rates. 

EUR/USD News

GBP/USD: The first downside target is seen at the 1.2600–1.2605 zone

GBP/USD: The first downside target is seen at the 1.2600–1.2605 zone

GBP/USD trades on a weaker note around 1.2620 during the early European session on Friday. The decline of Pound Sterling is backed by the growing speculation that the Bank of England will begin the rate-cut cycle this year.

GBP/USD News

Gold ends Q1 2024 at record highs, what’s next?

Gold ends Q1 2024 at record highs, what’s next?

Gold is sitting at an all-time high of $2,236, lacking a trading impetus amid holiday-thinned conditions on Good Friday. Most major world markets, including the United States are closed in observance of Holy Friday, leaving volatility around Gold price highly subdued.

Gold News

Ripple's move above this key level could trigger nearly 50% rally for XRP

Ripple's move above this key level could trigger nearly 50% rally for XRP

Ripple price has overcome a critical resistance level and flipped into a support floor on the weekly time frame. This development happened while XRP tightly consolidated for roughly 250 days.

Read more

US core PCE inflation set to ease in February on month as Federal Reserve rate cut bets for June mount

US core PCE inflation set to ease in February on month as Federal Reserve rate cut bets for June mount

The core Personal Consumption Expenditures Price Index is set to rise 0.3% MoM and 2.8% YoY in February. The revised Summary of Projections showed that policymakers upwardly revised end-2024 core PCE forecast to 2.6% from 2.4%.

Read more

Majors

Cryptocurrencies

Signatures